ArticleBritish journal of cancer2018

Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer.

Viswanath Gunda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.